Companies:

 

Articles:

 

Stock summary

Companies:

 

Kazia Therapeutics Limited (ASX: KZA)

 
Service provided by WebLinkIR

Company news

Cover Image for Kazia Therapeutics reveals 100% response rate in interim data from brain metastases drug trial

Kazia Therapeutics reveals 100% response rate in interim data from brain metastases drug trial

Cover Image for ‘World-leading’ brain cancer experts headline Kazia Therapeutics’ new scientific advisory board

‘World-leading’ brain cancer experts headline Kazia Therapeutics’ new scientific advisory board

Cover Image for Kazia Therapeutics awarded US FDA rare drug designation for paxalisib in childhood brain cancer

Kazia Therapeutics awarded US FDA rare drug designation for paxalisib in childhood brain cancer

Cover Image for Kazia Therapeutics reports good half-year progress despite market challenges

Kazia Therapeutics reports good half-year progress despite market challenges